ruthenium has been researched along with bromodeoxyuridine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergamo, A; Capozzi, I; Clerici, K; Cocchietto, M; Salerno, G; Sava, G | 1 |
1 other study(ies) available for ruthenium and bromodeoxyuridine
| Article | Year |
|---|---|
Modification of cell cycle and viability of TLX5 lymphoma in vitro by sulfoxide-ruthenium compounds and cisplatin detected by flow cytometry.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle; Cell Survival; Cisplatin; Dimethyl Sulfoxide; DNA, Neoplasm; Doxorubicin; Flow Cytometry; In Vitro Techniques; Lung Neoplasms; Lymphoma; Mice; Mice, Inbred CBA; Organometallic Compounds; Ruthenium; Tumor Cells, Cultured | 1998 |